0001209191-20-024687.txt : 20200416
0001209191-20-024687.hdr.sgml : 20200416
20200416194711
ACCESSION NUMBER: 0001209191-20-024687
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200414
FILED AS OF DATE: 20200416
DATE AS OF CHANGE: 20200416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIVEN DOUGLAS B
CENTRAL INDEX KEY: 0001156207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38042
FILM NUMBER: 20797460
MAIL ADDRESS:
STREET 1: C/O NEORX CORP
STREET 2: 410 WEST HARRISON ST
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARROWHEAD PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000879407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460408024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: SUITE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
BUSINESS PHONE: 626-696-4702
MAIL ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: SUITE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
FORMER COMPANY:
FORMER CONFORMED NAME: ARROWHEAD RESEARCH CORP
DATE OF NAME CHANGE: 20040112
FORMER COMPANY:
FORMER CONFORMED NAME: INTERACTIVE GROUP INC
DATE OF NAME CHANGE: 20020509
FORMER COMPANY:
FORMER CONFORMED NAME: INTERACTIVE INC
DATE OF NAME CHANGE: 19940224
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-14
0
0000879407
ARROWHEAD PHARMACEUTICALS, INC.
ARWR
0001156207
GIVEN DOUGLAS B
177 E. COLORADO BLVD
SUITE 700
PASADENA
CA
91105
1
0
0
0
Common Stock
2020-04-14
4
S
0
25000
36.89
D
155925
D
Common Stock
2020-04-14
5
G
0
E
1112
0.00
D
154813
D
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.63 to
$37.22, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead
Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares
sold at each separate price within the ranges set forth in this footnote of this Form 4.
/S/Douglass Given
2020-04-16